Drug intelligence / Profile preview

Biyan Qingdu Granules

Development stage
Unknown
Lead developer
Zhongshan Shaxi Chinese Medicine Factory
Administration
Oral
01

Overview

Biyan Qingdu Granules is a Traditional Chinese Medicine (TCM) product developed and manufactured by Zhongshan Shaxi Chinese Medicine Factory. It is formulated to clear heat, detoxify, and resolve phlegm and masses. The drug is primarily indicated as an adjuvant therapy for patients with nasopharyngeal carcinoma (NPC), particularly to alleviate symptoms and side effects associated with radiotherapy and chemotherapy, such as sore throat, nasal congestion, and headache. It is also used for the treatment of chronic nasopharyngitis. The formulation consists of a complex mixture of herbal ingredients, including *Paris polyphylla*, *Lonicera japonica*, and *Chrysanthemum indicum*, which are traditionally recognized for their anti-inflammatory and potential anti-tumor properties. It is approved for marketing in China and is administered orally.

Brand names
鼻咽清毒颗粒
Other names
Biyan Qingdu KeliBiyan Qingdu Ji
02

Targets

STAT3 (Signal Transducer and Activator of Transcription 3)AKT1 (Proto-oncogene serine/threonine-protein kinase Akt1)TP53 (Cellular Tumor Antigen p53 R175H)

Beyond the preview

Go deeper on Biyan Qingdu Granules.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Biyan Qingdu Granules.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call